Half-year report · HY
7129.TEDINET S100X0ZA
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥23.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥193m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥125m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥197m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥645m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥120m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥200m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥168m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥140m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥300m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥140m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥12.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥13.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥13.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥9.5bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥503m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥174m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥117m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥456m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥217m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥588m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥853m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥425m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥50.03 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.95 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.61 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥49.93 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥113.05 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.14 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥509m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥477m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥32m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥7m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥32m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥32m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥514m |
| Childcaresupport Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Childcaresupport Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.9bn |
| Childcaresupport Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥471m |
| Medicinereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Medicinereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥4.8bn |
| Medicinereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥203m |
| Nursing Care Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥27m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥11.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥11.5bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥701m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥32m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥708m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥468m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥444m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥493m |
| Childcaresupport Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Childcaresupport Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Childcaresupport Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥364m |
| Medicinereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Medicinereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Medicinereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥266m |
| Nursing Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Nursing Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥22m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥608m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥618m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 545
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)史彩監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 和 大 人 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)野 池 毅 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 11498846000 | JPY |
| Net sales (5-year summary) | InterimDuration | 11989169000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 23825724000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 120476000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 197396000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 644682000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 111855000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 139857000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 299868000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 111844000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 139865000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 299861000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 3480423000 | JPY |
| Net assets (5-year summary) | InterimInstant | 3887294000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 3794546000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 13166810000 | JPY |
| Total assets (5-year summary) | InterimInstant | 12451191000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 13277001000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 43.61 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 50.03 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 113.95 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | 43.14 | |
| Diluted earnings per share (5-year summary) | InterimDuration | 49.93 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 113.05 | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.264 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.312 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.286 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 174101000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 502593000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1010808000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -217435000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -116546000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -455500000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -424997000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | -587844000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -853399000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 1362457000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 1330899000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1532696000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2796300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2796300 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 2796300 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 2796300 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 836100 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.2990 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |